SEC Form 4 · accession 0001209191-16-121006
ImmunityBio, Inc. · IBRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael D Blaszyk
Director
Period of report
May 13, 2016
Accepted (ET)
May 17, 2016 · 6:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326110
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 13, 2016 | A | 50,000 | $0.00 | A | 50,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of NantKwest, Inc. common stock.
- F2Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through each applicable vesting date, the restricted stock units ("RSUs") will vest as follows: twenty five percent (25%) of the RSUs subject to the award shall vest on June 30, 2016, thereafter, twenty five percent (25%) of the RSUs subject to the award shall vest on June 30, 2017, and fifty percent (50%) of the RSUs subject to the award shall vest on June 30, 2019, such that the award shall be fully vested on June 30, 2019.